Mechanism of first-dose cytokine-release syndrome by CAMPATH 1-H: involvement of CD16 (FcgammaRIII) and CD11a/CD18 (LFA-1) on NK cells.

Mechanism of first-dose cytokine-release syndrome by CAMPATH 1-H: involvement of CD16 (FcgammaRIII) and CD11a/CD18 (LFA-1) on NK cells.

The administration of the immunosuppressive humanized monoclonal antibody CAMPATH 1-H, which recognizes CD52 on lymphocytes and monocytes, is associated with a first-dose cytokine-release syndrome involving TNFalpha, IFNgamma, and IL-6 clinically. In vitro models have been used to establish the cell...

書誌詳細
主要な著者:	Wing, MG, Moreau, T, Greenwood, J, Smith, R, Hale, G, Isaacs, J, Waldmann, H, Lachmann, P, Compston, A
フォーマット:	Journal article
言語:	English
出版事項:	1996

類似資料

Impact on T-cell depletion and CD34+ cell recovery using humanised CD52 monoclonal antibody (CAMPATH-1H) in BM and PSBC collections; comparison with CAMPATH-1M and CAMPATH-1G.
著者:: Williams, R, 等
出版事項: (2000)

Tolerance induction in the adult using monoclonal antibodies to CD4, CD8, and CD11a (LFA-1).
著者:: Waldmann, H, 等
出版事項: (1989)

TOLERANCE INDUCTION IN THE ADULT USING MONOCLONAL-ANTIBODIES TO CD4, CD8, AND CD11A (LFA-1)
著者:: Waldmann, H, 等
出版事項: (1989)

Association of Fcgamma receptor IIa (CD32) polymorphism with severe malaria in West Africa.
著者:: Cooke, G, 等
出版事項: (2003)

CAMPATH-1H in inflammatory arthritis.
著者:: Watts, R, 等
出版事項: (1993)

Peripheral blood dendritic cells express CD52 and are depleted in-vivo by treatment with CAMPATH-1H.
著者:: Buggins, A, 等
出版事項: (2001)

Crystal structures of a rat anti-CD52 (CAMPATH-1) therapeutic antibody Fab fragment and its humanized counterpart.
著者:: Cheetham, G, 等
出版事項: (1998)

CAMPATH-IH in multiple sclerosis.
著者:: Moreau, T, 等
出版事項: (1996)

Specificity of monoclonal antibody Campath-1.
著者:: Hale, G, 等
出版事項: (1988)

TREATMENT OF RHEUMATOID-ARTHRITIS WITH HUMANIZED ANTILYMPHOCYTE ANTIBODY CAMPATH-1H
著者:: Watts, R, 等
出版事項: (1992)

Inflammation, demyelination, and axonal degeneration: Three aspects of the pathogenesis of multiple sclerosis revealed by campath-1H treatment
著者:: Coles, A, 等
出版事項: (2003)

The tetraspanin CD53 modulates responses from activating NK cell receptors, promoting LFA-1 activation and dampening NK cell effector functions.
著者:: Izabela Todros-Dawda, 等
出版事項: (2014-01-01)

Campath-1H therapy in refractory ocular inflammatory disease.
著者:: Dick, A, 等
出版事項: (2000)

Availability of Campath-1 antibodies for bone marrow transplantation.
著者:: Hale, G, 等
出版事項: (1995)

CAMPATH-1 monoclonal antibodies in bone marrow transplantation.
著者:: Hale, G, 等
出版事項: (1994)

LFA-1 (CD11a/CD18) and Mac-1 (CD11b/CD18) distinctly regulate neutrophil extravasation through hotspots I and II
著者:: Young-Min Hyun, 等
出版事項: (2019-04-01)

Monoclonal antibody therapy of diffuse cutaneous scleroderma with CAMPATH-1H.
著者:: Isaacs, J, 等
出版事項: (1996)

The CAMPATH-1 antigen (CDw52).
著者:: Hale, G, 等
出版事項: (1990)

The lymphocyte function-associated LFA-1, CD2, and LFA-3 molecules: cell adhesion receptors of the immune system.
著者:: Springer, T, 等
出版事項: (1987)

TL1A increases expression of CD25, LFA-1, CD134 and CD154, and induces IL-22 and GM-CSF production from effector CD4 T-cells.
著者:: Kirsten Reichwald, 等
出版事項: (2014-01-01)

Identification of an ADAM17 cleavage region in human CD16 (FcγRIII) and the engineering of a non-cleavable version of the receptor in NK cells.
著者:: Yawu Jing, 等
出版事項: (2015-01-01)

T cell depletion with CAMPATH-1 in allogeneic bone marrow transplantation.
著者:: Hale, G, 等
出版事項: (1988)

Double T cell depletion of bone marrow using sequential positive and negative cell immunoaffinity or CD34+ cell selection followed by Campath-1M; effect on CD34+ cells and progenitor cell recoveries.
著者:: Clarke, E, 等
出版事項: (1998)

CAMPATH: from concept to clinic.
著者:: Waldmann, H, 等
出版事項: (2005)

Mechanisms of monoclonal antibody-facilitated tolerance induction: a possible role for the CD4 (L3T4) and CD11a (LFA-1) molecules in self-non-self discrimination.
著者:: Benjamin, R, 等
出版事項: (1988)

Recent results using CAMPATH-1 antibodies to control GVHD and graft rejection.
著者:: Hale, G, 等
出版事項: (1996)

Monoclonal antibody therapy of chronic intraocular inflammation using Campath-1H.
著者:: Isaacs, J, 等
出版事項: (1995)

HIV envelope gp120 activates LFA-1 on CD4 T-lymphocytes and increases cell susceptibility to LFA-1-targeting leukotoxin (LtxA)
著者:: Hioe, C, 等
出版事項: (2011)

HIV envelope gp120 activates LFA-1 on CD4 T-lymphocytes and increases cell susceptibility to LFA-1-targeting leukotoxin (LtxA).
著者:: Catarina E Hioe, 等
出版事項: (2011-01-01)

The effects of CAMPATH-1H on cell viability do not correlate to the CD52 density on the cell surface.
著者:: Fuiyee Lee, 等
出版事項: (2014-01-01)

Leukaemic relapse after Campath 1-treated bone-marrow transplantation for leukaemia.
著者:: Waldmann, H, 等
出版事項: (1987)

Prevention of immune-mediated corneal graft destruction with the anti-lymphocyte monoclonal antibody, CAMPATH-1H.
著者:: Newman, D, 等
出版事項: (1995)

CAMPATH-1 antibodies in stem-cell transplantation.
著者:: Hale, G, 等
出版事項: (2001)

TREM2 promotes natural killer cell development in CD3−CD122+NK1.1+ pNK cells
著者:: Hwa-Youn Lee, 等
出版事項: (2021-05-01)

CAMPATH-1 MOAB IN THE TREATMENT OF REFRACTORY AUTOIMMUNE THROMBOCYTOPENIC PURPURA (ATP)
著者:: Lim, S, 等
出版事項: (1993)

Campath-1 Abs 'in the bag' for hematological malignancies: the Cape Town experience.
著者:: Novitzky, N, 等
出版事項: (2004)

HIV transfer between CD4 T cells does not require LFA-1 binding to ICAM-1 and is governed by the interaction of HIV envelope glycoprotein with CD4
著者:: Juan Manel, 等
出版事項: (2008-03-01)

Flow cytometric visualisation of cytokine production by CD3-CD56+ NK cells and CD3+CD56+ NK-T cells in whole blood.
著者:: Mendes, R, 等
出版事項: (2000)

A personal history of the CAMPATH-1H antibody.
著者:: Waldmann, H
出版事項: (2002)

Efficient complement-mediated lysis of cells containing the CAMPATH-1 (CDw52) antigen.
著者:: Xia, M, 等
出版事項: (1993)